The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Does the Type of Ventilation Affect the Risk for Infections After Hip Replacements?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05932823
Recruitment Status : Completed
First Posted : July 6, 2023
Last Update Posted : July 6, 2023
Sponsor:
Collaborators:
University Hospital Bispebjerg and Frederiksberg, Søren Overgaard, Professor, Ph.D.
University Hospital Bispebjerg and Frederiksberg, Espen Jimenez Solem, Associate professor, Ph.D.
University Hospital Bispebjerg and Frederiksberg, Anne Helms Andreasen, Statistician
University Hospital Bispebjerg and Frederiksberg, Cathrine Uhrbrand Fox Maule, Data scientist
University Hospital Bispebjerg and Frederiksberg, Janne Pedersen, Statistician, PhD, Associate Professor
Information provided by (Responsible Party):
Jacob Moflag Svensson, MD, University Hospital Bispebjerg and Frederiksberg

Brief Summary:

Background: During hip replacement surgery, there is a risk that bacteria in the operating room can cause an infection. To try and reduce this risk, some operating rooms use a special system called laminar airflow (LAF), which reduces the number of bacteria in the air. However, it's not clear if LAF is better than the older system, called turbulent airflow (TAF), for preventing infections.

Aim: The aim of this study is to compare the two airflow systems and see if LAF is better at preventing infections after hip replacement surgery.

Methods: Information from a database containing all hip replacement surgeries done in Denmark between 2010 and 2020 is examined. The number of infections that occur in surgeries done with LAF, which reduces the number of bacteria in the air during surgery, is compared to the number of infections that occur in surgeries done with TAF. To make the results more credible, the data from the hip register was combined with data from the bacterial cultures taken during surgery.

Use and relevance: Infections after hip replacement surgery can be very serious and expensive to treat. Hospitals need to choose the best airflow system to help prevent these infections. This study is important because it gives more accurate information about which system is better at preventing infections and can help hospitals make better choices when they are designing or renovating operating rooms.


Condition or disease Intervention/treatment
Hip Prosthesis Infection Other: Laminary airflow

Show Show detailed description

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 110000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 12 Months
Official Title: Airflow and Hip Prosthesis Infections: A Registry Study Comparing Laminar vs. Turbulent Flow in the Danish Hip Arthroplasty Register.
Actual Study Start Date : January 1, 2010
Actual Primary Completion Date : December 31, 2021
Actual Study Completion Date : December 31, 2021

Group/Cohort Intervention/treatment
Laminar Airflow
total hip arthroplasty performed in an operating room using laminar airflow ventilation system
Other: Laminary airflow
A ventilation system that reduces the number of bacteria in the air compared to conventional ventilation.

Turbulent Airflow
total hip arthroplasty performed in an operating room using turbulent airflow ventilation system



Primary Outcome Measures :
  1. Revisions due to periprosthetic joint infections at 90 days after surgery [ Time Frame: t=90 days ]
    PJI is defined as revision with 2 or more positive biopsies with the same bacteria in MiBa or revision reported to DHR as PJI at t=90 days.

  2. Revisions due to periprosthetic joint infections at 365 days after surgery [ Time Frame: t=365 days ]
    PJI is defined as revision with 2 or more positive biopsies with the same bacteria in MiBa or revision reported to DHR as PJI at t=365 days.


Secondary Outcome Measures :
  1. Revisions due to aseptic loosening at 90 days after surgery [ Time Frame: t=90 days ]
    Aseptic loosening is defined as aseptic loosening being reported to DHR as reason for revision at t=90 days.

  2. Revisions due to aseptic loosening at 365 days after surgery [ Time Frame: t=365 days ]
    Aseptic loosening is defined as aseptic loosening being reported to DHR as reason for revision at t=365 days.

  3. Any revision at 90 days after surgery [ Time Frame: t=90 days ]
    Any revision is defined as revision being reported to DHR at t=90 days.

  4. Any revision at 365 days after surgery [ Time Frame: t=365 days ]
    Any revision is defined as revision being reported to DHR at t=365 days.


Other Outcome Measures:
  1. Sensitivity analysis: Alternative PJI diagnosis at 90 days [ Time Frame: t=90 days ]
    Primary revision registered as periprosthetic joint infection to DHR or with one or more positive biopsies of a bacterium at at t=90 days.

  2. Sensitivity analysis: Alternative PJI diagnosis at 365 days [ Time Frame: t=365 days ]
    Primary revision registered as periprosthetic joint infection to DHR or with one or more positive biopsies of a bacterium at at t=365 days.

  3. Sensitivity analysis: Viewing of which patients with 1 positive bacterial culture that receive antibiotics at 90 days [ Time Frame: t=90 ]
    Primary revision registered to DHR with 1 positive biopsy of a bacterium AND the prescription of a relevant antibiotic at t=90 days.

  4. Sensitivity analysis: Viewing of which patients with 1 positive bacterial culture that receive antibiotics at 365 days [ Time Frame: t=365 ]
    Primary revision registered to DHR with 1 positive biopsy of a bacterium AND the prescription of a relevant antibiotic at t=365 days.

  5. PJI in primary surgery between 2017-2020 at 90 days [ Time Frame: t=90 ]
    Analysis for the primary endpoint, but for data collected between 2017-2020, allowing for adjustment for BMI and ASA as possible confounders, as these variables are only registered in this period

  6. PJI in primary surgery between 2017-2020 at 365 days [ Time Frame: t=365 ]
    Analysis for the primary endpoint, but for data collected between 2017-2020, allowing for adjustment for BMI and ASA as possible confounders, as these variables are only registered in this period



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients 18 years or older undergoing total hip artroplasty in Denmark between January 1st 2010 - December 31st 2020, expected to be approximately 11.000 per year.
Criteria

Inclusion Criteria:

  • Primary Total hip arthroplasty performed in Denmark between 2010 and 2020

Exclusion Criteria:

  • Tumor or metastasis as indication for total hip arthroplasty
  Study Documents (Full-Text)

Documents provided by Jacob Moflag Svensson, MD, University Hospital Bispebjerg and Frederiksberg:
Additional Information:
Publications:
Hørder M, Bech M, Ejdrup Andersen S. Sundhedsstyrelsen, Dokumentation af Kvalitet og Standardisering Ventilation på operationsstuer København: Sundhedsstyrelsen, Dokumentation af Kvalitet og Standardisering, 2011 [Internet]. 2011 [cited 2023 May 16]. Available from: http://www.sst.dk/mtv
Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis [Internet]. New York, NY: Springer New York; 2001 [cited 2023 Jun 16]. (Springer Series in Statistics). Available from: http://link.springer.com/10.1007/978-1-4757-3462-1

Layout table for additonal information
Responsible Party: Jacob Moflag Svensson, MD, MD, University Hospital Bispebjerg and Frederiksberg
ClinicalTrials.gov Identifier: NCT05932823    
Other Study ID Numbers: P-2019-796
First Posted: July 6, 2023    Key Record Dates
Last Update Posted: July 6, 2023
Last Verified: June 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jacob Moflag Svensson, MD, University Hospital Bispebjerg and Frederiksberg:
Danish microbiology register
periprosthetic joint infection
laminar airflow
turbulent airflow
airflow
total hip arthroplasty
Danish hip arthroplasty register
ventilation system
total hip replacement
hip prosthesis infection
Additional relevant MeSH terms:
Layout table for MeSH terms
Infections
Communicable Diseases
Disease Attributes
Pathologic Processes